Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 20, 2020 - Issue 5
Submit an article Journal homepage
1,549
Views
11
CrossRef citations to date
0
Altmetric
Editorial

How can biosimilars change the trajectory of breast cancer therapy?

Dario TrapaniDivision of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy;Department of Oncology and Hemato-Oncology, University of Milan, Milan, ItalyORCID Iconhttps://orcid.org/0000-0003-1672-9560View further author information
ORCID Icon &
Giuseppe CuriglianoDivision of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy;Department of Oncology and Hemato-Oncology, University of Milan, Milan, ItalyCorrespondence[email protected]
View further author information
Pages 325-328 | Received 01 Dec 2019, Accepted 15 Apr 2020, Published online: 28 Apr 2020

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ali McBride, Karen MacDonald, Adolfo Fuentes-Alburo & Ivo Abraham. (2021) Cost-efficiency and expanded access modeling of conversion to biosimilar trastuzumab-dkst with or without pertuzumab in metastatic breast cancer. Journal of Medical Economics 24:1, pages 743-756.
Read now

Articles from other publishers (10)

Dario Trapani, Kiu Tay-Teo, Megan E. Tesch, Felipe Roitberg, Manju Sengar, Sara C. Altuna, Michael J. Hassett, Armando A. Genazzani, Aaron S. Kesselheim & Giuseppe Curigliano. (2022) Implications of Oncology Trial Design and Uncertainties in Efficacy-Safety Data on Health Technology Assessments. Current Oncology 29:8, pages 5774-5791.
Crossref
Bárbara Peliçário Vargas, Marcel Henrique Marcondes Sari & Luana Mota Ferreira. (2022) Trastuzumab in Breast Cancer Treatment: The Era of Biosimilars. Anti-Cancer Agents in Medicinal Chemistry 22:14, pages 2507-2516.
Crossref
G. Tini, D. Trapani, B.A. Duso, P. Beria, G. Curigliano, P.G. Pelicci & L. Mazzarella. (2022) Quantifying geographical accessibility to cancer clinical trials in different income landscapes. ESMO Open 7:3, pages 100515.
Crossref
Dario Trapani, Ophira Ginsburg, Temidayo Fadelu, Nancy U. Lin, Michael Hassett, Andre M. Ilbawi, Benjamin O. Anderson & Giuseppe Curigliano. (2022) Global challenges and policy solutions in breast cancer control. Cancer Treatment Reviews 104, pages 102339.
Crossref
Karen MacDonald, Neda Alrawashdh, Ali McBride & Ivo Abraham. (2021) Conversion to biosimilar pegfilgrastim-cbqv enables budget-neutral access to FOLFIRINOX treatment for metastatic pancreatic cancer. Future Oncology 17:33, pages 4561-4570.
Crossref
José Cleberson Santos Soares, Iago Dillion Lima Cavalcanti & Juliana Lúcia de Albuquerque Vasconcelos. (2021) Can biosimilar products be interchangeable? Pharmaceutical perspective in the implementation of biosimilars in oncology. Journal of Oncology Pharmacy Practice 27:6, pages 1491-1502.
Crossref
D. Trapani, C.G. Lengyel, B.S. Habeeb, S.C. Altuna, A. Petrillo, K. El Bairi, S. Hussain, S.A. Mazher, E.M. Elfaham, G. Curigliano & S.Z. Khan. (2021) The global landscape of availability, accessibility and affordability of essential diagnostics and therapeutics for the management of HER2-positive breast cancer: The ONCOLLEGE-001 survey. Journal of Cancer Policy 28, pages 100285.
Crossref
Michela Piezzo, Roberta D’Aniello, Ilaria Avallone, Bruno Barba, Daniela Cianniello, Stefania Cocco, Antonio D’Avino, Germira Di Gioia, Vincenzo Di Lauro, Giuseppina Fusco, Raffaele Piscitelli, Claudia von Arx, Michelino De Laurentiis & Piera Maiolino. (2021) Uptake of Trastuzumab Biosimilars for the Treatment of HER2-Positive Breast Cancer: A Real-World Experience from a Cancer Center. Pharmaceutics 13:5, pages 684.
Crossref
Çağla KÜÇÜK, Özlem ATEŞ DURU, Esra MUTLU & Hande KAZAK SARİLMİSER. (2021) Biyobenzer İlaçlar. Beykent Üniversitesi Fen ve Mühendislik Bilimleri Dergisi 13:2, pages 34-42.
Crossref
Hagar Elghazawy, Joaira Bakkach, Mohamed S Zaghloul, Atlal Abusanad, Mariam Mohamed Hussein, Mohamed Alorabi, Nermean Bahie eldin, Thanaa Helal, Tarek M Zaghloul, Bhanu Prasad Venkatesulu, Hesham Elghazaly & Sana Al-Sukhun. (2020) Implementation of breast cancer continuum of care in low- and middle-income countries during the COVID-19 pandemic. Future Oncology 16:31, pages 2551-2567.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.